Advertisement
Advertisement

TXG

TXG logo

10x Genomics, Inc. Class A Common Stock

61.54
USD
Sponsored
-3.31
-5.10%
Aug 28, 16:00 UTC -4
Closed
exchange

After-Market

61.23

-0.31
-0.51%

TXG Earnings Reports

Positive Surprise Ratio

TXG beat 16 of 28 last estimates.

57%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$148.71M
/
-$0.26
Implied change from Q2 26 (Revenue/ EPS)
-1.54%
/
+85.71%
Implied change from Q3 25 (Revenue/ EPS)
-0.20%
/
+18.18%

10x Genomics, Inc. Class A Common Stock earnings per share and revenue

On Aug 06, 2026, TXG reported earnings of -0.14 USD per share (EPS) for Q2 26, beating the estimate of -0.24 USD, resulting in a 43.09% surprise. Revenue reached 151.04 million, compared to an expected 148.26 million, with a 1.88% difference. The market reacted with a +14.10% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 16 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 148.71 million USD, implying an increase of 85.71% EPS, and decrease of -1.54% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Veeva Systems Inc.
Report Date
Aug 26, 2026 For Q2 27
Estimate
$2.26
Actual
$2.35
Surprise
+3.69%
logo
Evaxion A/S - ADR
Report Date
Aug 20, 2026 For Q2 26
Estimate
-$0.31
Actual
-$0.50
Surprise
-56.45%
FAQ
For Q2 2026, 10x Genomics, Inc. Class A Common Stock reported EPS of -$0.14, beating estimates by 43.09%, and revenue of $151.04M, 1.88% above expectations.
The stock price moved up 14.1%, changed from $45.60 before the earnings release to $52.03 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 16 analysts, 10x Genomics, Inc. Class A Common Stock is expected to report EPS of -$0.26 and revenue of $148.71M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement